Most Americans know Bayer (BAYN.DE) for its over-the-counter medicines like Aleve and Claritin. But that’s not all the company does. Bayer U.S. President Sebastian Guth tells Yahoo Finance’s Anjalee Khemlani that the company just opened a new facility to focus on cell and gene therapies to help treat diseases such as Parkinson’s. Guth also weighed in on the company’s acquisition of agricultural biotechnology company Monsanto. Guth says the company is “squarely focused on innovation in a space that continues to require innovation. Feeding the world is a very, very significant task and food is a medicine.” For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.
Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb
About Yahoo Finance:
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Yahoo Finance Plus: With a subscription to Yahoo Finance Plus get the tools you need to invest with confidence. Discover new opportunities with expert research and investment ideas backed by technical and fundamental analysis. Optimize your trades with advanced portfolio insights, fundamental analysis, enhanced charting, and more.
To learn more about Yahoo Finance Plus please visit: https://yhoo.it/33jXYBp
Connect with Yahoo Finance:
Get the latest news: https://yhoo.it/2fGu5Bb
Find Yahoo Finance on Facebook: http://bit.ly/2A9u5Zq
Follow Yahoo Finance on Twitter: http://bit.ly/2LMgloP
Follow Yahoo Finance on Instagram: http://bit.ly/2LOpNYz
Follow Yahoo Finance Premium on Twitter: https://bit.ly/3hhcnmV
I’ll pass
IT’S AMAZING THEY HAVEN’T REBRANDED. WE REALLY ARE SLEEP.
I was at a retirement seminar and the speaker spoke on how he quit his job after he made well over $950,000 PROFIT within 3months he invested $120,000. I just need creative ideas to afford my retirement.🚀
he is a popular broker, I can correctly say he’s worth his salt as a financial advisor as his diversification skills are top notch, because i see that in his results as my portfolio grows by averages of 10 to 15% on a monthly basis, unlike i can say for my IRA which has just been trudging along, my portfolio just mirrors what he trades and not just on some particular industries of my choosing.
he has a strong reputation and good insight when it comes to profiting from economic fluctuations. I trust ALEX L ORLOFF completely.